Nature Communications (Jan 2019)

The antimicrobial potential of Streptomyces from insect microbiomes

  • Marc G. Chevrette,
  • Caitlin M. Carlson,
  • Humberto E. Ortega,
  • Chris Thomas,
  • Gene E. Ananiev,
  • Kenneth J. Barns,
  • Adam J. Book,
  • Julian Cagnazzo,
  • Camila Carlos,
  • Will Flanigan,
  • Kirk J. Grubbs,
  • Heidi A. Horn,
  • F. Michael Hoffmann,
  • Jonathan L. Klassen,
  • Jennifer J. Knack,
  • Gina R. Lewin,
  • Bradon R. McDonald,
  • Laura Muller,
  • Weilan G. P. Melo,
  • Adrián A. Pinto-Tomás,
  • Amber Schmitz,
  • Evelyn Wendt-Pienkowski,
  • Scott Wildman,
  • Miao Zhao,
  • Fan Zhang,
  • Tim S. Bugni,
  • David R. Andes,
  • Monica T. Pupo,
  • Cameron R. Currie

DOI
https://doi.org/10.1038/s41467-019-08438-0
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 11

Abstract

Read online

Host microbiomes are feasible sources for drug discovery. Here, using large-scale isolations, bioactivity assays and omics, the authors uncover the antimicrobial potential of insect-associated Streptomyces and identify a compound, cyphomycin, active against multidrug-resistant fungal pathogens.